Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$548.38 USD
+3.60 (0.66%)
Updated Apr 22, 2024 04:00 PM ET
After-Market: $548.38 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$548.38 USD
+3.60 (0.66%)
Updated Apr 22, 2024 04:00 PM ET
After-Market: $548.38 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Zacks News
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Select Medical (SEM) Unveils Separation Plan for Concentra
by Zacks Equity Research
Select Medical (SEM) intends to separate its Concentra business in a bid to enhance shareholder value and boost growth prospects of strategically prioritized areas.
Thermo Fisher (TMO) End Markets Drive Growth Amid Macro Woes
by Zacks Equity Research
In the academic and government end markets, Thermo Fisher (TMO) is delivering strong growth in the electron microscopy, chromatography and mass spectrometry businesses.
Thermo Fisher Scientific (TMO) Laps the Stock Market: Here's Why
by Zacks Equity Research
In the closing of the recent trading day, Thermo Fisher Scientific (TMO) stood at $531.65, denoting a +0.37% change from the preceding trading day.
Thermo Fisher (TMO) Unveils CorEvitas Pharmacovigilance Platform
by Zacks Equity Research
Thermo Fisher (TMO) introduces the CorEvitas pharmacovigilance platform for clinical research registries.
Thermo Fisher's (TMO) PPD Business Backs BARDA's Clinical Trial
by Zacks Equity Research
Thermo Fisher's (TMO) PPD clinical research business is selected by BARDA to support the Phase II platform clinical trial to treat ARDS.
Why Thermo Fisher Scientific (TMO) Dipped More Than Broader Market Today
by Zacks Equity Research
Thermo Fisher Scientific (TMO) reachead $519.43 at the closing of the latest trading day, reflecting a -1.65% change compared to its last close.
Thermo Fisher (TMO) to Allocate IFA Testing Kits With New Pact
by Zacks Equity Research
Thermo Fisher (TMO) will continue to meet the evolving needs of laboratories and healthcare professionals by expanding its immunology product portfolio of EliA autoimmune diagnostics.
Thermo Fisher Scientific (TMO) Laps the Stock Market: Here's Why
by Zacks Equity Research
Thermo Fisher Scientific (TMO) reachead $521.52 at the closing of the latest trading day, reflecting a +0.57% change compared to its last close.
Thermo Fisher (TMO) Launches New Solutions for Clinical Labs
by Zacks Equity Research
Thermo Fisher (TMO) introduces the KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit to improve preanalytical workflows for clinical laboratories.
New Strong Sell Stocks for December 6th
by Zacks Equity Research
AESI, EQH and TMO have been added to the Zacks Rank #5 (Strong Sell) List on December 6, 2023.
Thermo Fisher (TMO) Advances Health Equity via New Partnership
by Zacks Equity Research
Thermo Fisher (TMO) announces a collaboration with Project HOPE to improve health outcomes by enabling expanded access to HIV testing and support services in Nigeria.
Idexx (IDXX) Up 11.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Thermo Fisher (TMO) Extends Partnership With Flagship Pioneering
by Zacks Equity Research
Thermo Fisher's (TMO) in-depth knowledge of the life sciences sector will be combined with Flagship Pioneering to create revolutionary capabilities for the ecosystem.
Why Is Thermo Fisher (TMO) Up 10.8% Since Last Earnings Report?
by Zacks Equity Research
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Dell Technologies and Thermo Fisher Scientific have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Dell Technologies and Thermo Fisher Scientific are part of the Zacks Bull and Bear of the Day article.
Bear of the Day: Thermo Fisher Scientific (TMO)
by Derek Lewis
Recent guidance cuts stemming from a challenging macroeconomic environment have caused shares to face adverse price action over recent months.
Market Awaits After-Hours Earnings Results
by Zacks Equity Research
Market Awaits After-Hours Earnings Results.
Q3 Earnings Mixed, Big Results Expected After-Hours
by Mark Vickery
The Dow is the sole major index in the green this morning, boosted by Microsoft's strong performance yesterday afternoon.
Thermo Fisher (TMO) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Thermo Fisher (TMO) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Thermo Fisher (TMO) Q3 Earnings Top Estimates, Margins Up
by Zacks Equity Research
Thermo Fisher's (TMO) PPI Business System and strong execution by its global team enabled the company to deliver strong financial performance for Q3.
Thermo Fisher Scientific (TMO) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Thermo Fisher (TMO) delivered earnings and revenue surprises of 1.97% and 0.04%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
The latest trading day saw Thermo Fisher Scientific (TMO) settling at $469.67, representing a +0.52% change from its previous close.
DexCom (DXCM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
DexCom (DXCM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for Thermo Fisher (TMO) in Q3 Earnings?
by Zacks Equity Research
Thermo Fisher (TMO) will likely gain from strong Analytical Instrument business performance and latest launches.
Thermo Fisher Scientific (TMO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.